Brokers Issue Forecasts for OTLK FY2026 Earnings
Outlook Therapeutics, Inc. (NASDAQ:OTLK – Free Report) – Research analysts at Brookline Capital Management decreased their FY2026 EPS estimates for shares of Outlook Therapeutics in a research note issued on Tuesday, May 27th. Brookline Capital Management analyst K. Dolliver now expects that the company will post earnings per share of $0.50 for the year, down […]
Outlook Therapeutics, Inc. (NASDAQ:OTLK – Free Report) – Research analysts at Brookline Capital Management decreased their FY2026 EPS estimates for shares of Outlook Therapeutics in a research note issued on Tuesday, May 27th. Brookline Capital Management analyst K. Dolliver now expects that the company will post earnings per share of $0.50 for the year, down […]
